John L. Beyer, MD: Patterns of Pharmacotherapy and Treatment Response in Elderly Adults with Bipolar Disorder

Name: John L. Beyer, MD: Patterns of Pharmacotherapy and Treatment Response in Elderly Adults with Bipolar Disorder
SKU: 4163
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 41 No. 1 Articles Tags: bipolar, bruce-burchitt, elderly, john-l-beyer, kenneth-gersing, md, pharmacotherapy, phd

Description

John L. Beyer, MD: Patterns of Pharmacotherapy and Treatment Response in Elderly Adults with Bipolar Disorder

Description

John L. Beyer, MD Link

EVIDENCE-BASED MEDICINE

Patterns of Pharmacotherapy and Treatment Response in Elderly Adults with Bipolar Disorder

John L. Beyer, MD, Bruce Burchitt, PhD, Kenneth Gersing, MD, and K. Ranga R. Krishnan, MD

David V. Sheehan, MD, MBA: The Speed of Onset of Action of Alprazolam-XR Compared to Alprazolam-CT in Panic Disorder

Larry Alphs, MD, PhD: Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale

David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder

John L. Beyer, MD: Patterns of Pharmacotherapy and Treatment Response in Elderly Adults with Bipolar Disorder

Description

John L. Beyer, MD Link

EVIDENCE-BASED MEDICINE

Patterns of Pharmacotherapy and Treatment Response in Elderly Adults with Bipolar Disorder

John L. Beyer, MD, Bruce Burchitt, PhD, Kenneth Gersing, MD, and K. Ranga R. Krishnan, MD

Related products

David V. Sheehan, MD, MBA: The Speed of Onset of Action of Alprazolam-XR Compared to Alprazolam-CT in Panic Disorder

Larry Alphs, MD, PhD: Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale

David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder

Ethical Issues In Schizophrenia: Considerations for Treatment and Research